Continuous Temperature Monitoring in Outpatient Adults
Yes, wearable continuous temperature monitoring devices are now available and feasible for outpatient adults, with FDA-cleared options like TempTraq® and CORE® demonstrating reliable performance for detecting fever episodes in high-risk populations.
Available Technology
Modern wearable temperature sensors enable continuous monitoring in the outpatient setting through:
- Axillary-worn patches that measure temperature every 2 minutes continuously 1, 2
- Core body temperature sensors that quantitatively measure blood perfusion rate to estimate arterial blood temperature 3
- Wireless transmission of data to healthcare providers for remote monitoring 1
The Verily Patch demonstrated strong performance in 86 high-risk patients post-chemotherapy, measuring body temperature with an error of only 0.35 ± 0.88°F compared to oral temperatures, achieving 90.2% sensitivity and 87.8% specificity for fever detection 1. Critically, this device detected fever episodes 14.3 times more frequently than standard clinic assessments, with a median lead time of 4.3 hours before clinical detection 1.
Clinical Applications
Continuous monitoring is particularly valuable for:
- Patients at high risk of febrile neutropenia after chemotherapy or stem cell transplantation 1, 2
- Post-cardiac arrest patients requiring temperature control (though these guidelines focus on inpatient settings) 4
- Diabetic patients with foot ulcers using at-home foot temperature monitoring to prevent ulcer recurrence 5
The technology addresses a critical gap: patient self-monitoring of temperature suffers from low accuracy and is impractical for extended periods 1. Intermittent temperature measurements can miss large fluctuations that continuous monitoring would capture 6.
Practical Considerations
Device placement and accuracy:
- Axillary placement is most common for wearable devices 1, 2
- Core temperature measurements (bladder, esophageal) remain the gold standard but are impractical for outpatients 7, 6
- Superficial measurements (skin, tympanic) are less accurate than core measurements but acceptable for continuous outpatient monitoring when using validated devices 6
Wear time and compliance:
- Patients in pilot studies wore devices for ≥95% of study duration (median 7 days) 1, 2
- Daily measurement requirements can be burdensome, particularly for patients without prior ulcer history 5
- False-positive and false-negative readings may affect patient confidence 5
Advanced Capabilities
Beyond simple fever detection, continuous temperature data enables:
- Machine learning-based diagnosis of fever etiology, with logistic regression models achieving 94% specificity for identifying engraftment fevers versus other causes 8
- Early intervention with median 4.3-hour lead time before clinical fever detection 1
- Pattern recognition of unique temperature signatures correlating with different disease processes 8
Implementation Barriers
Current limitations include:
- Cost and accessibility vary globally, raising equity concerns 5
- Infrastructure requirements for data transmission and healthcare provider monitoring 5
- Need for calibration and maintenance per manufacturer guidelines 7
- Limited widespread adoption in routine clinical practice outside research settings 5, 9
Recommendation for Clinical Practice
For high-risk outpatients (post-chemotherapy, immunocompromised, diabetic foot ulcer patients), prescribe FDA-cleared continuous temperature monitoring devices with wireless data transmission capabilities. Ensure patients receive training on device placement, understand the monitoring protocol, and have established communication pathways with healthcare providers for responding to fever alerts. For average-risk outpatients, intermittent oral temperature measurement remains adequate, though continuous monitoring technology is rapidly advancing and may become standard of care as costs decrease and evidence accumulates 1, 2.
The technology exists and works—the primary challenge is implementation at scale rather than technical feasibility.